Key facts
- Molecular You’s last known valuation is $25.0M (Apr 2024).
- It has raised $23.5M; the latest was Later Stage VC ($5.0M) in Aug 2025.
- Notable investors include Capital Factory, Scale Up Canada, CABHI, Life Sciences BC, WebSummit Vancouver — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Molecular You
- ·The full record, as it builds
Funding rounds
No funding rounds for Molecular You are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Molecular You
Developer of a comprehensive health assessment platform designed to analyze and interpret an individual's biological data. The company's platform analyzes blood-based biomarkers from a single blood sample to provide personalized, easy-to-read reports and tailored recommendations for diet and lifestyle, enabling healthcare providers to make informed decisions and proactively manage patients' health.
- Sector
- Healthcare
- HQ
- Vancouver, Canada
- Founded
- 2014
- Employees
- 30
- Website
- molecularyou.com/
- Ownership
- Privately Held (backing)
Molecular You doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Molecular You shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Molecular You in its N-PORT filings yet. We sweep new filings monthly.